There are days when Momma Kliff seems to be working overtime. Yep, just when you think things can’t get any wackier, they do. So let’s get right too it and look at some new items.
In the dah department Medtronic (NYSE: MDT) is touting the economic benefits of CGM and Type 2 patients. According to study published in the Journal of Medical Economics;
“Significant clinical benefits were observed for patients who used professional CGM. Economic benefits were observed for patients who utilized professional CGM more than once within a 1-year period or who used it during a . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.